Miguel Muñoz

The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug

Miguel Muñoz, Marisa Rosso · Investigational New Drugs · 2009 · 148 citations

Medicine, Immunology, Pharmacology +6

Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo

Michael Berger, Olaf Neth, Matthias Ilmer et al. · Journal of Hepatology · 2014 · 122 citations

Receptor Tyrosine Kinase, Liver Physiology, Hepatoblastoma Cells +8

The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines

Miguel Muñoz, Marisa Rosso, María José Robles‐Frías et al. · Laboratory Investigation · 2010 · 99 citations · Full text

Melanoma Cell Lines, Nk-1 Receptor, Human Melanoma +8

The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines

Miguel Muñoz, Marisa Rosso, Aleida Pérez et al. · Neuropeptides · 2005 · 92 citations

Nk1 Receptor, Mitogenic Action, Tumor Innervation +8

The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

Miguel Muñoz, Ana González-Ortega, Manuel Vicente Salinas-Martín et al. · International Journal of Oncology · 2014 · 83 citations · Full text

Breast Oncology, Oncology, Medicine +15